DK1148881T3 - Anvendelse af pyridazin[4,5-b]indol-1-acetamidderivater til fremstilling af medikamenter beregnet mod sygdomme forbundet med perifere benzodiazepinreceptorers dysfunktion - Google Patents

Anvendelse af pyridazin[4,5-b]indol-1-acetamidderivater til fremstilling af medikamenter beregnet mod sygdomme forbundet med perifere benzodiazepinreceptorers dysfunktion

Info

Publication number
DK1148881T3
DK1148881T3 DK00900637T DK00900637T DK1148881T3 DK 1148881 T3 DK1148881 T3 DK 1148881T3 DK 00900637 T DK00900637 T DK 00900637T DK 00900637 T DK00900637 T DK 00900637T DK 1148881 T3 DK1148881 T3 DK 1148881T3
Authority
DK
Denmark
Prior art keywords
pyridazine
indole
dysfunction
drugs
preparation
Prior art date
Application number
DK00900637T
Other languages
Danish (da)
English (en)
Inventor
Frank Marguet
Benoit Marabout
Jesus Benavides
Jacques Froissant
Philip Janiak
Badia Ferzaz
Yannick Evanno
Mireille Sevrin
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK1148881T3 publication Critical patent/DK1148881T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK00900637T 1999-01-26 2000-01-21 Anvendelse af pyridazin[4,5-b]indol-1-acetamidderivater til fremstilling af medikamenter beregnet mod sygdomme forbundet med perifere benzodiazepinreceptorers dysfunktion DK1148881T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9900806A FR2788696B1 (fr) 1999-01-26 1999-01-26 Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central

Publications (1)

Publication Number Publication Date
DK1148881T3 true DK1148881T3 (da) 2006-12-11

Family

ID=9541212

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00900637T DK1148881T3 (da) 1999-01-26 2000-01-21 Anvendelse af pyridazin[4,5-b]indol-1-acetamidderivater til fremstilling af medikamenter beregnet mod sygdomme forbundet med perifere benzodiazepinreceptorers dysfunktion

Country Status (32)

Country Link
US (1) US6395729B1 (ru)
EP (1) EP1148881B1 (ru)
JP (1) JP4688295B2 (ru)
KR (1) KR100694752B1 (ru)
CN (1) CN100577167C (ru)
AR (1) AR022413A1 (ru)
AT (1) ATE335487T1 (ru)
AU (1) AU764445B2 (ru)
BG (1) BG65152B1 (ru)
BR (1) BR0007718A (ru)
CA (1) CA2360754C (ru)
CO (1) CO5160242A1 (ru)
CY (1) CY1106257T1 (ru)
CZ (1) CZ294283B6 (ru)
DE (1) DE60029929T2 (ru)
DK (1) DK1148881T3 (ru)
EE (1) EE04905B1 (ru)
ES (1) ES2269097T3 (ru)
FR (1) FR2788696B1 (ru)
HK (1) HK1040905B (ru)
HU (1) HU228670B1 (ru)
IL (2) IL144181A0 (ru)
NO (1) NO321997B1 (ru)
NZ (1) NZ512981A (ru)
PL (1) PL193420B1 (ru)
PT (1) PT1148881E (ru)
RU (1) RU2243764C2 (ru)
SK (1) SK285707B6 (ru)
TR (1) TR200102134T2 (ru)
TW (1) TW541177B (ru)
UA (1) UA70349C2 (ru)
WO (1) WO2000044384A1 (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29061A (id) * 1998-12-02 2001-07-26 Pfizer Prod Inc METODE DAN KOMPOSISI UNTUK MEMPERBAIKI STABILITAS KONFORMASI SUATU PROTEIN DARI KELUARGA p53
FR2811897A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2838124B1 (fr) * 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
FR2876715B1 (fr) 2004-10-19 2006-12-15 Profiles Du Ct Sa Embout de protection pour ecran de glissiere de securite routiere
GT200600005A (es) * 2005-01-12 2006-08-16 Un derivado de 2-(aminocarbonilo ciclico)-indolina y una composicion farmaceutica que lo contiene
BRPI0611433A2 (pt) * 2005-05-05 2010-09-08 Sanofi Aventis Us Llc formulações estáveis de nanopartìcula
ME01560B (me) * 2005-08-29 2014-04-20 Sanofi Aventis Us Llc Amorfna čvrsta disperzija 7-hlor-n,n,5-trimetil-4-okso-3-fenil-3,5,-dihidr0-4h-piridazino[4,5-b]indol-1-acetamida
JP5063600B2 (ja) 2005-08-29 2012-10-31 サノフイ−アベンテイス・ユー・エス・エルエルシー ピリダジノ［４，５−ｂ］インドール誘導体の新規な結晶形
CN1946120B (zh) * 2006-10-20 2010-05-12 华为技术有限公司 实现话单关联的方法及系统
FR2918563B1 (fr) 2007-07-12 2009-12-04 Oreal Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire.
FR2931064B1 (fr) 2008-05-14 2010-08-13 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane
EP2364315A1 (en) * 2008-08-18 2011-09-14 Sanofi-Aventis U.S. LLC Process for preparing polymorph of 7-chloro-n, n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydr0-4h-pyridazin0[4,5-b]indole-1-acetamide
GB0818738D0 (en) * 2008-10-13 2008-11-19 Ge Healthcare Ltd Imaging neuroflammation
FR2936706B1 (fr) 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
EP2181717A1 (en) 2008-10-28 2010-05-05 Sanofi-Aventis Use of 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-B]indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels
JP2013514316A (ja) 2009-12-18 2013-04-25 ロレアル インサイチュで縮合することができる化合物を含む美容処理方法
FR2960773B1 (fr) 2010-06-03 2015-12-11 Oreal Procedes de traitement cosmetique utilisant un revetement a base d'un polymere polyamide-polyether
WO2019113248A1 (en) * 2017-12-07 2019-06-13 The Regents Of The University Of California Anti-upar antibody-drug conjugates and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3121137A1 (de) * 1981-05-27 1982-12-16 Hoechst Ag, 6000 Frankfurt Neue pyridazino(4,5-b)indole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und deren herstellung"
GB9411955D0 (en) * 1994-06-15 1994-08-03 Merck Sharp & Dohme Therapeutic agents
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
US6031120A (en) * 1997-07-29 2000-02-29 E. I. Du Pont De Nemours And Company Selective synthesis of organodiphosphite compounds
FR2766823B1 (fr) * 1997-07-30 1999-10-08 Synthelabo Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2788776B1 (fr) * 1999-01-26 2001-02-23 Synthelabo Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
PT1148881E (pt) 2006-12-29
ES2269097T3 (es) 2007-04-01
WO2000044384A1 (fr) 2000-08-03
KR20010089624A (ko) 2001-10-06
CZ20012681A3 (cs) 2001-10-17
KR100694752B1 (ko) 2007-03-14
PL193420B1 (pl) 2007-02-28
SK10502001A3 (sk) 2002-01-07
EE200100388A (et) 2002-12-16
EP1148881A1 (fr) 2001-10-31
BR0007718A (pt) 2001-11-13
CO5160242A1 (es) 2002-05-30
SK285707B6 (sk) 2007-06-07
CN1344161A (zh) 2002-04-10
FR2788696B1 (fr) 2004-03-05
IL144181A (en) 2007-06-17
NO321997B1 (no) 2006-07-31
TW541177B (en) 2003-07-11
AR022413A1 (es) 2002-09-04
HK1040905B (zh) 2007-02-23
NO20013645D0 (no) 2001-07-24
JP2002535370A (ja) 2002-10-22
BG105728A (en) 2002-02-28
EP1148881B1 (fr) 2006-08-09
UA70349C2 (en) 2004-10-15
AU764445B2 (en) 2003-08-21
CN100577167C (zh) 2010-01-06
CZ294283B6 (cs) 2004-11-10
NZ512981A (en) 2002-10-25
DE60029929T2 (de) 2007-08-30
HUP0201280A2 (en) 2002-08-28
NO20013645L (no) 2001-09-26
AU3057900A (en) 2000-08-18
ATE335487T1 (de) 2006-09-15
CA2360754A1 (en) 2000-08-03
HU228670B1 (en) 2013-05-28
IL144181A0 (en) 2002-05-23
CY1106257T1 (el) 2011-06-08
PL349364A1 (en) 2002-07-15
RU2243764C2 (ru) 2005-01-10
EE04905B1 (et) 2007-10-15
HUP0201280A3 (en) 2004-12-28
HK1040905A1 (en) 2002-06-28
JP4688295B2 (ja) 2011-05-25
CA2360754C (en) 2008-07-08
FR2788696A1 (fr) 2000-07-28
DE60029929D1 (de) 2006-09-21
US6395729B1 (en) 2002-05-28
BG65152B1 (bg) 2007-04-30
TR200102134T2 (tr) 2003-03-21

Similar Documents

Publication Publication Date Title
DK1148881T3 (da) Anvendelse af pyridazin[4,5-b]indol-1-acetamidderivater til fremstilling af medikamenter beregnet mod sygdomme forbundet med perifere benzodiazepinreceptorers dysfunktion
DE69827419D1 (de) Pharmazeutische Zusammensetzung, enthaltend 2,3-Diaryl-Pyrazolo[1,5-b]Pyridazin Derivate
ID29514A (id) 2-ARIL-3-(HETEROARIL)-IMIDAZO [1,2-a]PIRIMIDIN TERSUBSTITUSI, DAN METODE-METODE DAN KOMPOSISI-KOMPOSISI FARMASI YANG TERKAIT
NO20002977D0 (no) Terapeutisk formulering for administrasjon av tolterodin med kontrollert frigivelse
AU4583899A (en) Nasal administration of sildenafil for the treatment of erectile dysfunction
HK1045646A1 (zh) 蛋白質穩定化的藥理學活性劑，其製備方法及其使用方法
NO20005841D0 (no) Pyrrolo[1,2-b]pyridazinderivater med sPLA2inhiberende effekt
PT1674456E (pt) Utilização de 2-fluoro-3-cetoésteres para preparar 3-fluoro- 6,7,8,9-tetra-hidro-4-h-pirimido[1,2-a]pirimidin-4-onas
EE200100377A (et) Imidaso[1,5-a]-pürido[3,2-e]-pürasinoonide kasutamine arstimitena
EP1440689A3 (en) Treatment of neurotic disorders
NZ515882A (en) Treatment of serotonin related disorders with 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives
DE60002043D1 (de) 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]indol-1-carboxamid-derivate, ihre herstellung und therapeutische verwendung
NO20000605D0 (no) 3-Substituerte 3,4,5,7-tetrahydro-pyrrolo[3',4':4,5]tieno[2,3- D]pyrimidinderivater, deres fremstilling og anvendelse som 5HT- antagonister
DK1071397T3 (da) Levosimendan-holdige lægemidler til oral indgivelse med kontrolleret frisætning af det aktive middel
NO20001894L (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
MXPA03008894A (es) Uso de compuestos de imidazo[1,2-a]-piridin-3-il-amidas e imidazo [1,2-a]-piridin-3-il-aminas sustituidas como medicamentos.
HUP0002736A3 (en) 3-substituted pyrido [3',4':4,5]thieno[2,3-d]pyrimidine derivatives, and their use for the preparation of pharmaceutical compositions
AU2001278549A1 (en) Use of pyridazino(4,5-)indole-1-acetamide derivatives for preparing medicines for treating pathologies related to the dysfunction of peripheral benzodiazepin receptors
PL371201A1 (en) 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
AU3971800A (en) 2-alkoxy-cyclobutene-3,4-dione derivatives, preparation and therapeutic use thereof
IL203601A (en) 6-Hello-7-History (optionally converted amino) -Pyrazolo [15, - a] pyrimidine and its use in drug preparation
TW382948U (en) Improved structure for the leg locking structure of chairs
EE200100700A (et) Asendatud [1,4]diasepino[6,7,1-hi]indool-4-oonidevalmistamismeetod
ITRM20010767A1 (it) Uso di 5.11-diidro-6h-dipirido1/4 3,2-b:2',3'-e|1/4 1.4|diazepine per la preparazione di composizioni farmaceutiche antitumorali.
GB0312101D0 (en) Use of pyrazolo[1,5-B]pyridazine derivatives for the treatment of psychiatric disorders